FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898486585> ?p ?o ?g. }

• W2898486585 endingPage "2426" @default.
• W2898486585 startingPage "2424" @default.
• W2898486585 abstract "Neurofibromatosis-1 phenotype combined with webbed neck and short stature in a young Omani patient was revealed to be due to a de novo germ-line heterozygous 1.7 Mb microdeletion at 17q11.2. This lead to the diagnosis of NF1 microdeletion syndrome. We present a first case report from Oman of a 20-month-old male child presenting with a neurofibromatosis-1 phenotype combined with webbed neck and short stature. Comprehensive molecular testing revealed a de novo germ-line heterozygous 1.7 Mb microdeletion at 17q11.2, which lead to the diagnosis of NF1 microdeletion syndrome. We present a case of a 20-month-old male child, born prematurely (33 weeks) with IUGR (intrauterine growth restriction) after elective cesarean section to a mother who had a history of a previous abortion and one healthy offspring. The index patient presented here was the product of a non-consanguineous marriage and has no family history of dysmorphic or disability syndromes. After birth, the patient was admitted to the neonatal intensive unit for 25 days. He initially presented with abnormal facial features and developmental delay and was referred to our center for further evaluation and management at 2 years of age. Along with delayed development, the patient mainly presented with the clinical features in Table 1, which were highly suggestive of Neurofibromatosis Type 1 (NF1) associated with mutations in the NF1 gene. The patient also exhibited short stature, webbed neck, and cardiac defect at birth, (which resolved with time) all symptoms which are commonly seen in Noonan syndrome (NS) patients. This led to a preliminary diagnosis of Neurofibromatosis-Noonan syndrome (NFNS) in this patient (Figure 1). NFNS is typically described as a rare autosomal dominant disorder with combined clinical features of NF1 and Noonan syndrome (NS).1 To confirm this diagnosis, the patient was referred for molecular genetic testing to the laboratory at our center where the patient's blood was collected after informed parental consent. DNA was extracted from the patient's blood and processed for next-generation sequencing (NGS) using the Ion AmpliSeq Comprehensive Cancer panel (CCP) on the Ion S5 from Ion Torrent (ThermoFisher Scientific) to probe for mutations in the NF1 gene and three of the most significant genes causing NS, namely PTPN11, SOS1, and KRAS. Since the CCP is also validated in our laboratory for use as a preliminary screen for copy number variants above 200 kb, we were able to detect an apparent 279 kb deletion at the 17q11.2 (hg19) locus using NGS. This 279 kb deleted region indicated a single copy loss for five non-consecutive genes present within the 17q11.2 locus, including the NF1 gene. This signified the presence of a microdeletion event at this locus. However, NGS cannot reliably provide information regarding the full extent of microdeletions or their breakpoints because NGS results only reflect the genes probed by the specific panel, which are likely less than the actual number of genes or regions deleted. In view of establishing the diagnosis of neurofibromatosis, we used the Multiplex ligation probe amplification (MLPA) kits from MRC Holland (P081-D1 and P082-C2) to confirm the complete heterozygous NF1 gene deletion (exons 1-58) in the index patient. Since the index patient presented with webbed neck and relatively severe developmental delay, features rarely seen in NF1 patients, we further sought to delineate the microdeletion breakpoint regions and characterize the genes in the deleted locus. The patient DNA was processed for comparative genomic hybridization (CGH) array on the Affymetrix platform using the CytoScan HD kit, and data analysis was carried out using the CHAS software (v.3.1.0.15). CGH array analysis revealed a heterozygous microdeletion of almost 1.7 Mb in the distal part of chromosome 17 (17q11.2) in the index patient. This 1.7 Mb microdeletion region {arr[hg19]17q11.2(28,838,381-30,533,034) x1} actually included 22 genes, of which 11 were OMIM genes [CRLF3 (614853), ATAD5 (609534), ADAP2 (608635), RNF135 (611358), NF1 (613113), OMG (164345), EVI2B (158381), EVI2A (158380), RAB11FIP4 (611999), MIR193A (614733), SUZ12 (606245)]. Out of these 11 OMIM genes, only two genes, RNF135 and NF1 were associated with disease phenotypes. A previous study on a patient with haploinsufficiency of the RNF135 gene due to a microdeletion encompassing RNF135 and another four genes, but excluding NF1, suggested that haploinsufficiency of RNF135 may contribute to the overgrowth, facial dysmorphism, learning disabilities and other congenital anomalies exhibited by patients with NF1 microdeletions.2 However, despite the absence of one RNF135 gene copy, our patient did not show any overgrowth symptoms, although facial dysmorphism was noted. On the contrary, the patient continued to exhibit short stature till last clinical visit 8 months ago. Given the preliminary diagnosis of NFNS, we sought to rule out Noonan syndrome by analyzing all the associated genes (A2ML1, BRAF, CBL, HRAS, KRAS,MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, SOS1, SPRED1) using a custom NGS panel. However, no pathogenic or candidate variants were detected in these genes. Hence, our comprehensive testing resulted in revising the diagnosis from NFNS to NF1 microdeletion syndrome in our patient; the first such case to be reported in Oman. Although a 1.7 Mb microdeletion associated with the NF1 gene was previously reported elsewhere using the FISH technique in 1999,3 it was present in mosaic form. Moreover, the range of the region and the genes deleted were not well defined, likely due to the lack of advanced CGH array technology at the time. It is not surprising that patients with mutations in the NF1 gene can also present with features overlapping with those seen in NS patients, considering that both the NF1 gene and the NS genes express proteins which are integral components of the RAS-MAPK developmental pathways during embryogenesis.4 Also, the complete loss of one of the alleles of the NF1 gene is the probable cause of the relatively more severe and earlier presentation of cognitive abnormalities and dysmorphism in our patient, a phenomenon also observed in previous reports of NF1 microdeletions.5-9 Although SNP analysis using array CGH indicated that the microdeleted allele was maternal in origin, no genomic abnormality was detected in either parent. Hence, we concluded that this 1.7 Mb microdeletion within the 17q11.2 region probably occurred as a de novo event. The clinical management protocol adopted for this patient was based on the international guidelines for NF1 patients, which primarily focus on the evaluation and treatment of complications.10, 11 We referred the patient to appropriate specialists as part of a management plan to include regular clinical evaluation, assessment of developmental milestones and annual ophthalmologic examination to enable early or preventive interventions. A periodic follow-up using magnetic resonance imaging (MRI) for potential intracranial tumors and other internal tumors was also implemented. The authors of this manuscript have no conflict of interests to declare. MA: conducted clinical sampling, patient counseling, and manuscript review. NH: carried out molecular genetic analyses and wrote the manuscript. AAY, HAM, AE, AAA: carried out cytogenetic and molecular cytogenetic analyses. SAH: supervised cytogenetic work. LH: carried out molecular genetic work-up. WM: carried out manuscript review." @default.
• W2898486585 created "2018-11-02" @default.
• W2898486585 creator A5013486320 @default.
• W2898486585 creator A5052388740 @default.
• W2898486585 creator A5060097509 @default.
• W2898486585 creator A5060882127 @default.
• W2898486585 creator A5061889704 @default.
• W2898486585 creator A5068564162 @default.
• W2898486585 creator A5072328578 @default.
• W2898486585 creator A5089759352 @default.
• W2898486585 creator A5090515640 @default.
• W2898486585 date "2018-10-26" @default.
• W2898486585 modified "2023-10-16" @default.
• W2898486585 title "Rare NF1 microdeletion syndrome in an Omani patient" @default.
• W2898486585 cites W1526966306 @default.
• W2898486585 cites W1978140725 @default.
• W2898486585 cites W1992091196 @default.
• W2898486585 cites W2005508652 @default.
• W2898486585 cites W2006382721 @default.
• W2898486585 cites W2010926229 @default.
• W2898486585 cites W2029130057 @default.
• W2898486585 cites W2035457862 @default.
• W2898486585 cites W2085699375 @default.
• W2898486585 cites W2110235266 @default.
• W2898486585 cites W2415139834 @default.
• W2898486585 doi "https://doi.org/10.1002/ccr3.1881" @default.
• W2898486585 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6293151" @default.
• W2898486585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30564341" @default.
• W2898486585 hasPublicationYear "2018" @default.
• W2898486585 type Work @default.
• W2898486585 sameAs 2898486585 @default.
• W2898486585 citedByCount "1" @default.
• W2898486585 countsByYear W28984865852021 @default.
• W2898486585 crossrefType "journal-article" @default.
• W2898486585 hasAuthorship W2898486585A5013486320 @default.
• W2898486585 hasAuthorship W2898486585A5052388740 @default.
• W2898486585 hasAuthorship W2898486585A5060097509 @default.
• W2898486585 hasAuthorship W2898486585A5060882127 @default.
• W2898486585 hasAuthorship W2898486585A5061889704 @default.
• W2898486585 hasAuthorship W2898486585A5068564162 @default.
• W2898486585 hasAuthorship W2898486585A5072328578 @default.
• W2898486585 hasAuthorship W2898486585A5089759352 @default.
• W2898486585 hasAuthorship W2898486585A5090515640 @default.
• W2898486585 hasBestOaLocation W28984865851 @default.
• W2898486585 hasConcept C104317684 @default.
• W2898486585 hasConcept C127716648 @default.
• W2898486585 hasConcept C187212893 @default.
• W2898486585 hasConcept C2776984250 @default.
• W2898486585 hasConcept C54355233 @default.
• W2898486585 hasConcept C71924100 @default.
• W2898486585 hasConcept C86803240 @default.
• W2898486585 hasConceptScore W2898486585C104317684 @default.
• W2898486585 hasConceptScore W2898486585C127716648 @default.
• W2898486585 hasConceptScore W2898486585C187212893 @default.
• W2898486585 hasConceptScore W2898486585C2776984250 @default.
• W2898486585 hasConceptScore W2898486585C54355233 @default.
• W2898486585 hasConceptScore W2898486585C71924100 @default.
• W2898486585 hasConceptScore W2898486585C86803240 @default.
• W2898486585 hasIssue "12" @default.
• W2898486585 hasLocation W28984865851 @default.
• W2898486585 hasLocation W28984865852 @default.
• W2898486585 hasLocation W28984865853 @default.
• W2898486585 hasLocation W28984865854 @default.
• W2898486585 hasOpenAccess W2898486585 @default.
• W2898486585 hasPrimaryLocation W28984865851 @default.
• W2898486585 hasRelatedWork W1995515455 @default.
• W2898486585 hasRelatedWork W2080531066 @default.
• W2898486585 hasRelatedWork W2109699714 @default.
• W2898486585 hasRelatedWork W2409957712 @default.
• W2898486585 hasRelatedWork W2410491650 @default.
• W2898486585 hasRelatedWork W2604682584 @default.
• W2898486585 hasRelatedWork W2748952813 @default.
• W2898486585 hasRelatedWork W2899084033 @default.
• W2898486585 hasRelatedWork W3032375762 @default.
• W2898486585 hasRelatedWork W3081816203 @default.
• W2898486585 hasVolume "6" @default.
• W2898486585 isParatext "false" @default.
• W2898486585 isRetracted "false" @default.
• W2898486585 magId "2898486585" @default.
• W2898486585 workType "article" @default.